Cannabinoid index · Varin cannabinoid
THCV (tetrahydrocannabivarin) is a minor cannabinoid of the cannabis plant and a close chemical cousin of THC. Its side chain has three carbon atoms instead of five [1]. That small change matters. At most doses THCV blocks the CB1 receptor that THC switches on, and only at higher doses does it begin to act like THC [2][3]. In people, 10 mg of THCV taken by mouth felt no different from a placebo [5]. Research interest centres on blood sugar and appetite, but the human trials so far are small and short [7].
How THCV forms in the plant
Cannabis builds most of its cannabinoids from CBGA, which carries a five-carbon side chain. The varin cannabinoids start from a sister molecule, CBGVA, which the plant makes from divarinolic acid. The enzyme THCA synthase turns CBGVA into THCVA, the acid form found in raw flower. Heat or light then removes the acid group and leaves THCV [1]. CBDV comes from the same varin precursor [1].
Most flower contains THCV only in very small amounts. Breeders are developing cultivars with more of it, and THCV-dominant cultivars remain rare [1][3].
Does THCV get you high?
Not at the doses found in most products. THCV binds the same CB1 receptor as THC, but at most biologically relevant doses it blocks the receptor rather than activating it. At higher doses it can act as an agonist, the way THC does [2][3]. Animal work shows both sides: in a 2025 rat study, 3 mg/kg of THCV partly mimicked THC, while 6 mg/kg reversed the effect of a THC dose [4].
The human data point the same way. Ten healthy male volunteers took 10 mg of THCV a day for five days; on its own it was well tolerated and could not be told apart from placebo [5]. In a dose-ranging study of the delta-8 form, healthy adults took single oral doses from 12.5 to 200 mg. Only 100 and 200 mg raised ratings of feeling and liking a drug effect, and those THC-like effects were mild and not linked to impairment [6].
For scale: 10 mg of THC by mouth reliably intoxicates, and most THCV consumer products contain less than 5 mg of THCV [3]. Delta-8-THCV has not been reported in the plant; it appears to be semi-synthetic, made by isomerising CBDV with acid [3].
THCV vs THC
| Property | THCV | THC |
|---|---|---|
| Side chain | Propyl, 3 carbons [1] | Pentyl, 5 carbons [1] |
| Molecular formula | C19H26O2 [9] | C21H30O2 [12] |
| Action at CB1 | Antagonist at most doses, agonist at higher doses [3] | Partial agonist [3] |
| 10 mg by mouth | Indistinguishable from placebo [3][5] | Reliably intoxicating [3] |
| Acid form in raw flower | THCVA [1] | THCA [8] |
The two names look alike, but the authors of a 2025 review conclude that THCV and THC should not be placed in the same category of psychoactive compounds [3].
What the human research found
Blood sugar. A pilot trial enrolled 62 adults with type 2 diabetes who were not on insulin, split across five groups for 13 weeks. THCV at 5 mg twice a day lowered fasting plasma glucose by 1.2 mmol/L compared with placebo and improved a measure of insulin-producing beta-cell function. It did not change HDL cholesterol, the trial's main outcome, and it was well tolerated [7][8].
THC effects. In the five-day study, THCV taken before an intravenous THC dose blunted THC's rise in heart rate, and nine of ten men rated the THC as weaker. THCV with THC also increased memory intrusions, and the authors stress the small sample [5].
Food reward. A brain-imaging study found that THCV increased responses to unpleasant food stimuli in brain areas linked to food aversion [1].
Is THCV "diet weed"?
The nickname runs ahead of the evidence. Appetite and weight claims rest mostly on animal work and on small, short human studies [1][7]. Even in mice the picture is mixed: in obese mice THCV improved glucose tolerance and raised energy expenditure, but it did not reduce food intake or body weight [1]. This page does not recommend THCV for weight loss or for any condition.
Decarboxylation and infusion
Raw flower holds THCV as its acid, THCVA. Heat or light converts it to THCV [1], the same kind of reaction that turns THCA into THC [8]. No published study found for this page measured temperatures and times for THCVA itself, so it gives no THCV-specific setting. For what research measured on THCA, see the decarboxylation temperature chart.
Sport and drug tests
The World Anti-Doping Agency prohibits all natural and synthetic cannabinoids in competition, with cannabidiol as the only exception, so THCV is covered [11]. In the delta-8-THCV study, 78 of 79 urine drug screens taken 8 hours after an active dose came back positive for THC [6].
What is established, and what is not
Established: THCV is a natural varin cannabinoid with dose-dependent action at CB1, it is not intoxicating at the low doses studied in people, and small human trials have been run [3][5][7]. Not established: any proven benefit for weight, appetite or diabetes in everyday use. The trials are small, short and few. This page describes the compound and summarises research; it is not medical advice.
Frequently asked questions
Does THCV get you high?
Not at low doses. 10 mg by mouth felt like placebo in a human study [5]. Mild THC-like effects appeared only at 100 and 200 mg of the delta-8 form [6].
What does THCV do in the body?
It binds the CB1 receptor. At most doses it blocks the receptor; at higher doses it can activate it, as THC does [2][3].
Does THCV actually work?
The evidence is early. One 13-week pilot trial in 62 adults with type 2 diabetes found lower fasting glucose with THCV than with placebo [7]. No large trial has confirmed a benefit.
Which is stronger, THCA or THCV?
Neither is strongly intoxicating as it stands. THCA becomes THC when heated [8], and 10 mg of THC by mouth reliably intoxicates, while 10 mg of THCV does not [3].
Why is THCV rare?
Most cannabis makes far more of the five-carbon cannabinoids than the varins. THCV usually appears in very small amounts, and THCV-dominant cultivars are rare [1][3].
Sources
- Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Frontiers in Pharmacology. 2021;12:777804. doi:10.3389/fphar.2021.777804
- Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta-9-tetrahydrocannabinol, cannabidiol and delta-9-tetrahydrocannabivarin. British Journal of Pharmacology. 2008;153(2):199-215. doi:10.1038/sj.bjp.0707442
- Haghdoost M, Peters EN, Roberts M, Bonn-Miller MO. Tetrahydrocannabivarin is Not Tetrahydrocannabinol. Cannabis and Cannabinoid Research. 2025;10(1):1-5. doi:10.1089/can.2024.0051
- Kayir H, Kouroukis L, Aziz I, Khokhar JY. Tetrahydrocannabivarin (THCV) Dose Dependently Blocks or Substitutes for Tetrahydrocannabinol (THC) in a Drug Discrimination Task in Rats. Biomolecules. 2025;15(9):1329. doi:10.3390/biom15091329
- Englund A, Atakan Z, Kralj A, Tunstall N, Murray R, Morrison P. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: a placebo-controlled, double-blind, crossover pilot trial. Journal of Psychopharmacology. 2016;30(2):140-151. doi:10.1177/0269881115615104
- Peters EN, MacNair L, Harrison A, et al. A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Delta-8-Tetrahydrocannabivarin in Healthy Participants. Cannabis and Cannabinoid Research. 2023;8(S1):S71-S82. doi:10.1089/can.2023.0038
- Jadoon KA, Ratcliffe SH, Barrett DA, et al. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. Diabetes Care. 2016;39(10):1777-1786. doi:10.2337/dc16-0650
- Abioye A, Ayodele O, Marinkovic A, Patidar R, Akinwekomi A, Sanyaolu A. Delta-9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. Journal of Cannabis Research. 2020;2:6. doi:10.1186/s42238-020-0016-7
- PubChem. Tetrahydrocannabivarin, CID 93147. National Library of Medicine. pubchem.ncbi.nlm.nih.gov/compound/93147
- Cayman Chemical. Tetrahydrocannabivarin, product information, item 30748 (CAS number and formula weight). caymanchem.com
- World Anti-Doping Agency. Prohibited List 2026, S8 Cannabinoids (prohibited in competition; cannabidiol excepted). wada-ama.org
- PubChem. Tetrahydrocannabinol, CID 16078. National Library of Medicine. pubchem.ncbi.nlm.nih.gov/compound/16078
Part of the cannabinoid index.
Educational information about a compound. Not medical advice or guidance on use.